Heidi S. Harvie, MD, MBA, MSCE

she/her/hers
Urogynecology
Accepting new patients
Sees patients age 16 and up
Penn Urogynecology Washington Square
Penn Medicine Provider

About me

  • Director, Penn Urogynecology & Pelvic Reconstructive Surgery, Pennsylvania Hospital
  • Associate Professor of Obstetrics and Gynecology at the Pennsylvania Hospital

My education and training

  • Medical School: University of Pennsylvania School of Medicine
  • Residency: University of Pennsylvania Health System
  • Fellowship: University of Pennsylvania Health System

Spoken languages

English
English

Reviews

Average Rating

533 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Anonymous
August 2026
she is the best!
Anonymous
August 2026
explaining everything and showing me visually so i could understand everything.
Anonymous
August 2026
approachable knowledgeable doctor.
Anonymous
August 2026
knowledgeable and friendly

Insurance accepted

Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.

Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Harvie is a Penn Medicine physician.

Qualifications and experience

Treatments and conditions

Research

Publications

Harvie HS, Honeycutt AA, Carper B, Menefee S, Siddiqui N, Ellington D, Rardin C, Jeney SE, Glass Clark S, Mazloomdoost D, Thomas S, for the NICHD Pelvic Floor Disorders Network Cost Effectiveness of vaginal mesh hysteropexy vs hysterectomy/USLS: SUPeR Trial. , Urogynecology: 2026 *ACCEPTED


Gilmore E, McAllister A, Russell LB, Montoya M, Koelper NC, Schreiber CA, Harvie HS Validity and Responsiveness of EQ-5D-5L in the Abortion Care Setting. , American J Obstet Gynecol , 234(4): 2026,1121–1129


Agrawal S, Ikpeama N, Koelper N, Dokras A, Harvie H, Hamm RF, Dutcher L, Arya LA A Randomized Trial of a Texting Platform for Recurrent Urinary Tract Infections. , Urogynecology, 32(3): 2026,62–171


Lukacz ES, Menefee SA, Carper B, Collins S, McMillian K, Florian-Rodriguez M, Rardin C, Weidner AC, Harvie HS, Alexander B, Mazloomdoost D, NICHD Pelvic Floor Disorders Network Design of Transurethral Bulking Agent Injection Versus Single-Incision SlingTrial. , Urogynecology, 32(2): 2026,131–141


Harvie HS, Chermansky C, Richter HE Midurethral Sling vs OnabotulinumtoxinA for Urinary Incontinence-Reply , JAMA, 334(16): 2025,1488-1489


Muñoz JM, Kim EK, Andy UU, Mumford SL, Harvie HS Variation in Overactive Bladder Treatment Type by Social Determinants of Health. , Urogynecology, 31(10): 2025,929-941


Walter JR, Richards EG, Johannesson L, Falcone T, Testa G, O'Neill KE, Harvie HS Cost-effectiveness Analysis of Uterus Transplantation versus Gestational Carrier for Treatment of Absolute Uterine Factor Infertility. , Fertil Steril, 124(1): 2025,121-133


Reaves S, Levin, PJ, Harvie HS, Andy UU Factors Affecting Follow-up for Specialty Postpartum Care after Obstetric Anal Sphincter Injury at a Single U.S. Institution. , Int Urogynecol J, 36(7): 2025,1457-1463


Harvie HS, Menefee SA, Richter HE, Sung VW, Chermansky CJ, Rahn DD, Amundsen CL, Arya LA, Rhodes E, Mazloomdoost D, Thomas S, National Institute of Child Health and Human Development Pelvic Floor Disorders Network Midurethral Sling vs OnabotulinumtoxinA in Females With Urinary Incontinence: The MUSA Randomized Clinical Trial. , JAMA, 333(21): 2025,1887-1896


Arya LA, Agrawal S, Ikpeama N, Harvie HS, Feldman RH, Dutcher L Implementing a Digital Platform for Recurrent Urinary Tract Infections. , Urogynecology, 31(3): 2025,183-193